Difficulty falling or staying asleep — where sleep peptides and low-risk supplements are explored.
Insomnia spans sleep onset and maintenance, with many drivers. The compounds of interest are the delta-sleep peptide DSIP, the timing signal melatonin, and well-tolerated supports like magnesium and ashwagandha for the stress component.
Sleep hygiene and CBT-I are the evidence-based first line. The supplements are low-risk adjuncts; DSIP remains a research compound. Chronic insomnia deserves a proper look at causes rather than indefinite self-medication.
Ranked by editorial relevance — a measure of how central each compound is to the conversation, not a claim of effectiveness.
| Compound | Type | Why it's relevant |
|---|---|---|
| DSIP | peptide | Delta-sleep-inducing peptide; evening dose. |
| Melatonin | supplement | Sleep-timing signal; low dose usually enough. |
| Ashwagandha | supplement | Adaptogen for the stress component. |